Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential vs Cyclic Teriparatide and Denosumab for Osteoporosis
NCT02130973Phase 4Unknown
- Sponsor
- Health Research, Inc.
- Start
- Aug 2013
- Primary completion
- Aug 2018
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of teriparatide, denosumab in osteoporosis, sponsored by Health Research, Inc.. Status: unknown.
02
Drugs
teriparatidedenosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02130973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02130973.